Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Early detection of thrombin activity in neuroinflammatory disease.
Is neuropsychological rehabilitation effective in multiple sclerosis?
Inflammatory Cytokines and Physical Activity in Multiple Sclerosis.
Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.
Different Mechanisms Regulate Expression of Zebrafish Myelin P0 in Myelinating Oligodendrocytes and its Induction Following Axonal Injury.
Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event.
Sex drive and sexual desire.
High avidity chimeric monoclonal antibodies against the extracellular domains of human aquaporin-4 competing with NMO-IgG.
Phosphorus-Based Dendrimer ABP Treats Neuroinflammation by Promoting IL-10-Producing CD4(+) T Cells.
Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients.
Glatiramer Acetate 40 Mg/Ml Three Times A Week for The Treatment of Relapsing Forms of Multiple Sclerosis: Potential Cost Benefits of A Regimen With Infrequent Injections Which May Minimise Switching to The Newly-Introduced First-Line and Second-Line Dise
Multiple sclerosis-Indian perspective.
Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis.
Mechanisms of remyelination: recent insight from experimental models.
Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis.
Walking Speed and Brain Glucose Uptake are Uncoupled in Patients with Multiple Sclerosis.
Cell Fusion along the Anterior-Posterior Neuroaxis in Mice with Experimental Autoimmune Encephalomyelitis.
Protein-protein interaction analysis highlights additional Loci of interest for multiple sclerosis.
The pathological and physiological roles of IL-6 amplifier activation.
Targeting estrogen receptor β in microglia and T cells to treat experimental autoimmune encephalomyelitis.
Utility of the Canadian Treatment Optimization Recommendations (TOR) in MS Care.
Superficial brain stimulation in multiple sclerosis.
A case of fulminant neuromyelitis optica presenting with destructive lesions in whole-brain.
Russell W Brain and the aetiology of multiple sclerosis--a historical perspective.
An initial top-down proteomic analysis of the standard cuprizone mouse model of multiple sclerosis.
Pages
« first
‹ previous
…
592
593
594
595
596
597
598
599
600
…
next ›
last »